The use of Ginkgo biloba in healthy elderly

Age

Volumn 36, Issue 1, 2014, Pages 435-444

  Franke, Andreas G ^a   Heinrich, Isabel ^a   Lieb, Klaus ^a   Fellgiebel, Andreas ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Cognitive decline; Cognitive enhancement; Dementia; Elderly; Ginkgo biloba

Indexed keywords

GINGIUM; GINKGO BILOBA EXTRACT; GINKOBIL; HERBACEOUS AGENT; UNCLASSIFIED DRUG; VITAMIN;

ADULT; AGED; AGING; ALTERNATIVE MEDICINE; ARTICLE; AWARENESS; BIVARIATE ANALYSIS; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; DIET SUPPLEMENTATION; FEMALE; GERIATRICS; GINKGO BILOBA; HEALTH BEHAVIOR; HEALTH INSURANCE; HUMAN; HUMAN EXPERIMENT; IMMUNE SYSTEM; KNOWLEDGE; MALE; MEDICAL INFORMATION; MEMORY; MENTAL PERFORMANCE; MULTIVARIATE ANALYSIS; NONHUMAN; NORMAL HUMAN; OUTCOME ASSESSMENT; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRACTICE GUIDELINE; PREVALENCE; PSYCHOSOMATICS; QUESTIONNAIRE; SEX DIFFERENCE; TEACHING; TINNITUS; TRADITIONAL MEDICINE; TREATMENT INDICATION; UNIVERSITY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; COGNITION DISORDERS; DEMOGRAPHY; DIETARY SUPPLEMENTS; FEMALE; GERMANY; GINKGO BILOBA; HEALTH BEHAVIOR; HUMANS; MALE; MIDDLE AGED; PHYTOTHERAPY; QUESTIONNAIRES;

EID: 84899049261     PISSN: 01619152     EISSN: 15744647     Source Type: Journal    
DOI: 10.1007/s11357-013-9550-y     Document Type: Article

References (53)

1. Abebe W, Herman W, Konzelman J (2011) Herbal supplement use among adult dental patients in a USA dental school clinic: prevalence, patient demographics, and clinical implications. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 111(3):320-325
2. Adusumilli PS, Ben-Porat L, Pereira M, Roesler D, Leitman IM (2004) The prevalence and predictors of herbal medicine use in surgical patients. J Am Coll Surg 198(4):583-590 (Pubitemid 38446533)
3. Ahlemeyer B, Krieglstein J (2003) Neuroprotective effects of Ginkgo biloba extract. Cell Mol Life Sci 60(9):1779-1792 (Pubitemid 37222578)
4. Baltes PB (1997) On the incomplete architecture of human ontogeny. Selection, optimization, and compensation as foundation of developmental theory. Am Psychol 52(4):366-380
5. Barnes PM, Bloom B, Nahin RL (2008) Complementary and alternative medicine use among adults and children: United States, 2007. Natl Health Stat Report 12:1-23
6. Bastianetto S, Zheng WH, Quirion R (2000) The Ginkgo biloba extract (EGb 761) protects and rescues hippocampal cells against nitric oxide-induced toxicity: involvement of its flavonoid constituents and protein kinase C. J Neurochem 74(6):2268-2277 (Pubitemid 30314201)
7. Birks J, Grimley Evans J (2007) Ginkgo biloba for cognitive impairment and dementia. Cochrane Database Syst Rev (2):CD003120
8. Birks J, Grimley Evans J (2009) Ginkgo biloba for cognitive impairment and dementia. Cochrane Database Syst Rev (1):CD003120
9. Birks J, Grimley EV, Van Dongen M (2002) Ginkgo biloba for cognitive impairment and dementia. Cochrane Database Syst Rev (4):CD003120
10. Blumenthal M (1997) Herbal market levels after five years of boom. HerbalGram 47:64-5
11. Bradley CP (1992) Uncomfortable prescribing decisions: a critical incident study. BMJ 304(6822):294-296
12. Brayne C (2007) The elephant in the room - healthy brains in later life, epidemiology and public health. Nat Rev Neurosci 8(3):233-239
13. de Jongh R, Bolt I, Schermer M, Olivier B (2008) Botox for the brain: enhancement of cognition, mood and pro-social behavior and blunting of unwanted memories. Neurosci Biobehav Rev 32(4):760-776
14. DeFeudis FV, Drieu K (2000) Ginkgo biloba extract (EGb 761) and CNS functions: basic studies and clinical applications. Curr Drug Targets 1(1):25-58
15. Dietz P, Striegel H, Franke AG, Lieb K, Simon P, Ulrich R (2013): Randomized Response Estimates for the One-Year Prevalence of Cognitive Enhancement in University Students. Pharmacotherapy, (in press)
16. Dlugosch G, Krieger W (1995) Fragebogen zur Erfassung des Gesundheitsverhaltens: FEG. Swets Test Services, Frankfurt
17. Fowler JS, Wang GJ, Volkow ND, Logan J, Franceschi D, Franceschi M, MacGregor R, Shea C, Garza V, Liu N, Ding YS (2000) Evidence that gingko biloba extract does not inhibit MAO A and B in living human brain. Life Sci 66(9):PL141-PL146
18. Franke AG, Lieb K (2010) Pharmacological neuroenhancement and brain doping : Chances and risks. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 53(8):853-859
19. Franke AG, Lieb K, Fellgiebel A (2009) From symptomatic to disease modifying therapy? Recent developments in the pharmacotherapy of Alzheimer 's disease. Fortschr Neurol Psychiatr 77(6):326-333
20. Franke AG, Bonertz C, Christmann M, Lieb K (2012) Attitudes Toward Cognitive Enhancement in Users and Nonusers of Stimulants for Cognitive Enhancement: A Pilot Study. AJOB Prim Res 3(1):48-57
21. Franke GH (2002) SCL-90-R: Die symptom checkliste von L. R. Derogatis. Göttingen: Beltz Test GmbH
22. Goldberg DP, Blackwell B (1970) Psychiatric illness in general practice. A detailed study using a new method of case identification. Br Med J 1(5707):439-443
23. Hui EK, Rubenstein LZ (2006) Promoting physical activity and exercise in older adults. J Am Med Dir Assoc 7(5):310-314 (Pubitemid 43852788)
24. Jeste DV, Depp CA, Vahia IV (2010) Successful cognitive and emotional aging. World Psychiatry 9(2):78-84
25. Kanowski S, Herrmann WM, Stephan K, Wierich W, Horr R (1996) Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia. Pharmacopsychiatry 29(2):47-56 (Pubitemid 26116561)
26. Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA (2002) Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. Jama 287(3):337-344 (Pubitemid 34251967)
27. Kelly JP, Kaufman DW, Kelley K, Rosenberg L, Anderson TE, Mitchell AA (2005) Recent trends in use of herbal and other natural products. Arch Intern Med 165(3):281-286 (Pubitemid 40216279)
28. Lasher KP, Faulkender PJ (1993) Measurement of aging anxiety: development of the Anxiety about Aging Scale. Int J Aging Hum Dev 37(4):247-259 (Pubitemid 24002352)
29. Le Bars PL, Katz MM, Berman N, Itil TM, Freedman AM, Schatzberg AF (1997) A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group Jama 278(16):1327-1332 (Pubitemid 27449692)
30. Lewis PJ, Tully MP (2011) The discomfort caused by patient pressure on the prescribing decisions of hospital prescribers. Res Social Adm Pharm 7(1):4-15
31. Lohaus A, Schmitt GM (1998) Fragebogen zur Erhebung von Kontrollüberzeugungen zu Krankheit und Gesundheit (KKG). Hogrefe, Göttingen
32. Maclennan KM, Darlington CL, Smith PF (2002) The CNS effects of Ginkgo biloba extracts and ginkgolide B. Prog Neurobiol 67(3):235-257 (Pubitemid 34880132)
33. Maher B (2008) Poll results: look who's doping. Nature 452(7188):674-675
34. Maier W (2010) Diagnose- und Behandlungsleitlinie Demenz: Interdisziplinäre S3-Praxisleitlinien. Springer, Berlin
35. Morris CA, Avorn J (2003) Internet marketing of herbal products. Jama 290(11):1505-1509 (Pubitemid 37430407)
36. Oyama Y, Chikahisa L, Ueha T, Kanemaru K, Noda K (1996) Ginkgo biloba extract protects brain neurons against oxidative stress induced by hydrogen peroxide. Brain Res 712(2):349-352 (Pubitemid 26106099)
37. Pearson N, Biddle SJ, Gorely T (2009) Family correlates of fruit and vegetable consumption in children and adolescents: a systematic review. Public Health Nutr 12(2): 267-283
38. Rhodes RE, Martin AD, Taunton JE, Rhodes EC, Donnelly M, Elliot J (1999) Factors associated with exercise adherence among older adults. An individual perspective. Sports Med 28:397-411 (Pubitemid 30015826)
39. Rimbach G, Wolffram S, Watanabe C, Packer L, Gohil K (2003) Effect of Ginkgo biloba (EGb 761) on differential gene expression. Pharmacopsychiatry 36(Suppl 1):S95-S99 (Pubitemid 37047016)
40. Rowe JW, Kahn RL (1987) Human aging: usual and successful. Science 237(4811):143-149 (Pubitemid 17095916)
41. Schneider LS (2012) Ginkgo and AD: key negatives and lessons from GuidAge. Lancet Neurol 11(10):836-837
42. Schuler H (2006) Lehrbuch der Personalpsychologie. Göttingen: Hogrefe
43. Smith ME, Farah MJ (2011) Are prescription stimulants "smart pills"? The epidemiology and cognitive neuroscience of prescription stimulant use by normal healthy individuals. Psychol Bull 137(5):717-741
44. Solomon PR, Adams F, Silver A, Zimmer J, DeVeaux R (2002) Ginkgo for memory enhancement: a randomized controlled trial. Jama 288(7):835-840
45. Stern Y, Gurland B, Tatemichi TK, Tang MX, Wilder D, Mayeux R (1994) Influence of education and occupation on the incidence of Alzheimer 's disease. Jama 271(13):1004-1010 (Pubitemid 24099921)
46. van der Bij AK, Laurant MG, Wensing M (2002) Effectiveness of physical activity interventions for older adults: a review. Am J Prev Med 22(2):120-133 (Pubitemid 34119127)
47. Vellas B, Coley N, Ousset PJ, Berrut G, Dartigues JF, Dubois B, Grandjean H, Pasquier F, Piette F, Robert P, Touchon J, Garnier P, Mathiex-Fortunet H, Andrieu S (2012) Long-term use of standardised Ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial. Lancet Neurol 11(10):851-859
48. Vollmar HC, Mand P, Butzlaff ME (2008) DEGAM-Leitlinie Nr. 12: Demenz. Stand: 2008. Omikron Publ, Düsseldorf
49. Walley T (2002) Lifestyle medicines and the elderly. Drugs Aging 19(3):163-168
50. Watkins RE, Coates R, Ferroni P (1998) Measurement of aging anxiety in an elderly Australian population. Int J Aging Hum Dev 46(4):319-332 (Pubitemid 28292674)
51. Watts D, Damasco-Ty E, Ryan F, Goodman B (2001) Geriatricians health survey 2000. J Am Geriatr Soc 49(11):1535-1538 (Pubitemid 33051407)
52. Weinmann S, Roll S, Schwarzbach C, Vauth C, Willich SN (2010) Effects of Ginkgo biloba in dementia: systematic review and meta-analysis. BMC Geriatr 10:14
53. Youn JC, Kim KW, Lee DY, Jhoo JH, Lee SB, Park JH, Choi EA, Choe JY, Jeong JW, Choo IH, Woo JI (2009)Development of the Subjective Memory Complaints Questionnaire. Dement Geriatr Cogn Disord 27(4):310-317